Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans

Diabetes Care

Volumn 22, Issue 1, 1999, Pages 65-70

  Mcneely, Marguerite J ^a   Chessler, Steven D ^a   Boyko, Edward J ^a,b   Leonnetti, Donna L ^c   Weigle, David S ^a   Fujimoto, Wilfred Y ^a   Shofer, Jane B ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Epidemiologic Res and Info Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; LEPTIN;

ADULT; ARTICLE; BLOOD LEVEL; BODY FAT; CONTROLLED STUDY; DIABETES MELLITUS; DIABETOGENESIS; ETHNIC GROUP; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE;

ADIPOSE TISSUE; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; JAPAN; LEPTIN; MALE; MIDDLE AGED; OBESITY; PREDICTIVE VALUE OF TESTS; PROTEINS; RISK FACTORS; WASHINGTON;

EID: 0344026285     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.1.65     Document Type: Article

References (41)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432, 1994
2. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543-546, 1995
3. Jacob RJ, Dziura J, Medwick MB, Leone P, Caprio S, During M, Shulman GI, Sherwin RS: The effect of leptin is enhanced by microinjection into the ventromedial hypothalamus. Diabetes 46:150-152, 1997
4. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte J-M, Basdevant A, Bougneres P, Leboue Y, Froguel P, Guy-Grand B: A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392:398-401, 1998
5. Montague CT, Farooqi S, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JC, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O'Rahilly S: Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387:903-908, 1997
6. Hasstedt SJ, Hoffman M, Leppert MF, Elbein SC: Recessive inheritance of obesity in familial non-insulin-dependent diabetes mellitus, and lack of linkage to nine candidate genes. Am J Hum Genet 61:668-677, 1997
7. Considine RV, Considine EL, Williams CJ, Hyde TM, Caro JF: The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations. Diabetes 45:992-994, 1996
8. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295, 1996
9. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV: Leptin: the tale of an obesity gene. Diabetes 45:1455-1462, 1996
10. Zimmet P, Hodge A, Nicolson M, Staten M, de Courten M, Moore J, Morawiecki A, Lubina J, Collier G, Alberti G, Dowse G: Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study. BMJ 313:965-969, 1996
11. Malmstrom R, Taskinen MR, Karonen SL, Yki-Janinen H: Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia 39:993-996, 1996
12. Saad MF, Damani S, Gingerich RL, Riad-Gabriel MG, Khan A, Boyadjian R, Jinagouda SD, El-Tawil K, Rude RK, Kamdar V: Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab 82:579-584, 1997
13. Schwartz MW, Prigeon RL, Kahn SE, Nicolson M, Moore J, Morawiecki A, Boyko EJ, Porte D Jr: Evidence that plasma leptin and insulin levels are associated with body adiposity via different mechanisms. Diabetes Care 20:1476-1481, 1997
14. Widjaja A, Stratton IM, Horn R, Holman RR, Turner R, Brabant G: UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects. J Clin Endocrinol Metab 82:654-657, 1997
15. Hanley AJ, Hams SB, Gao XJ, Kwan J, Zinman B: Serum immunoreactive leptin concentrations in a Canadian aboriginal population with high rates of NIDDM. Diabetes Care 20:1408-1415, 1997
16. Mohamed-Ali V, Pinkney JH, Panahloo A, Goodrick S, Coppack SW, Yudkin JS: Relationships between plasma leptin and insulin concentrations, but not insulin resistance, in non-insulin-dependent (type 2) diabetes mellitus. Diabet Med 14:376-380, 1997
17. Kolaczynski JW, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry R, Mudaliar SR, Olefsky J, Caro JF: Acute and chronic effects of insulin on leptin production in humans: studies in vivo and in vitro. Diabetes 45:699-701, 1996
18. Schmitz O, Fisker S, Orskov L, Hove KY, Nyholm B, Moller N: Effects of hyperinsulinaemia and hypoglycaemia on circulating leptin levels in healthy lean males. Diabetes Metab 23:80-83, 1997
19. Saad MF, Khan A, Sharma A, Michael R, Riad-Gabriel MG, Boyadjian R, Jinagouda SD, Steil GM, Kamdar V: Physiological insulinemia acutely modulates plasma leptin. Diabetes 47:544-549, 1998
20. Barr VA, Malide D, Zarnowski MJ, Taylor SI, Cushman SW: Insulin stimulates both leptin secretion and production by rat white adipose tissue. Endocrinology 138:4463-4472, 1997
21. Kieffer TJ, Heller RS, Habener JF: Leptin receptors expressed on pancreatic beta-cells. Biochem Biophys Res Commun 224:522-527, 1996
22. Kulkarni RN, Wang ZL, Wang RM, Hurley JD, Smith DM, Ghatei MA, Withers DJ, Gardiner JV, Bailey CJ, Bloom SR: Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest 100:2729-2736, 1997
23. + channels in pancreatic β-cells. Diabetes 46:1087-1093, 1997
24. Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q, Garvey WT: The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab 82:1293-1300, 1997
25. McGregor GP, Desaga JF, Ehlenz K, Fischer A, Heese F, Hegele A, Lammer C, Peiser C, Lang RE: Radiommunological measurement of leptin in plasma of obese and diabetic human subjects. Endocrinology 137:1501-1504, 1996
26. Haffner SM, Mykkanen L, Stern MP: Leptin concentrations in women in the San Antonio Heart Study: effect of menopausal status and postmenopausal hormone replacement therapy. Am J Epidemiol 146:581-585, 1997
27. de Courten M, Zimmet P, Hodge A, Collins V, Nicolson M, Staten M, Dowse G, Alberti KG: Hyperleptinaemia: the missing link in the metabolic syndrome? Diabet Med 14:200-208, 1997
28. Clement K, Lahlou N, Ruiz J, Hager J, Bougneres P, Basdevant A, Guy-Grand B, Froguel P: Association of poorly controlled diabetes with low serum leptin in morbid obesity. Int J Obes 21:556-561, 1997
29. Fujimoto WY, Leonetti DL, Kinyoun JL, Newell-Morris L, Shuman WP, Stolov WC, Wahl PW: Prevalence of diabetes mellitus and impaired glucose tolerance among second-generation Japanese-Amencan men. Diabetes 36:721-729, 1987
30. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
31. Boyko EJ, Leonetti DL, Bergstrom RW, Newell-Morris L, Fujimoto WY: Visceral adiposity, fasting plasma insulin, and blood pressure in Japanese-Amencans. Diabetes Care 18:174-181, 1995
32. Matthews DR, Hosker JP, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
33. Howard G, Bergman R, Wagenknecht LE, Haffner SM, Savage PJ, Saad MF, Laws A, D'agostino RB: Ability of alternative indices of insulin sensitivity to predict cardiovascular risk: comparison with the "minimal model." Ann Epidemiol 8:358-369, 1998
34. Chessler SD, Fujimoto WY, Shofer JB, Boyko EJ, Weigle DS: Increased plasma leptin levels are associated with fat accumulation in Japanese Americans. Diabetes 47:239-243, 1998
35. Weigle DS, Ganter SL, Kuijper JL, Leonetti DL, Boyko EJ, Fujimoto WY: Effect of regional fat distribution and Prader-Willi syndrome on plasma leptin levels. J Clin Endocrinol Metab 82:566-570, 1997
36. Shuman WP, Morris LL, Leonetti DL, Wahl PW, Moceri VM, Moss AA, Fujimoto WY: Abnormal body fat distribution detected by computed tomography in diabetic men. Investigative Radiology 21:483-487, 1986
37. Ramachandran A, Snehalatha C, Vijay V, Satyavani K, Latha E, Haffner SM: Plasma leptin in non-diabetic Asian Indians: association with abdominal adiposity. Diabet Med 14:937-941, 1997
38. Ravussin E, Pratley RE, Maffei M, Wang H, Friedman JM, Bennett PH, Bogardus C: Relatively low plasma leptin concentrations precede weight gain in Pima Indians. Nat Med 3:238-240, 1997
39. Dua A, Hennes MI, Hoffmann RG, Maas DL, Krakower GR, Sonnenberg GE, Kissebah AH: Leptin: a significant indicator of total body fat but not of visceral fat and insulin insensitivity in African-American women. Diabetes 45:1635-1637, 1996
40. Bergstrom RW; Newell-Morris LL, Leonetti DL, Shuman WP, Wahl PW, Fujimoto WY: Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes 39:104-111, 1990
41. Rothman KJ, Greenland S: Precision and validity in epidemiologic studies. In Modern Epidemiology. 2nd ed. Rothman KJ, Greenland S, Eds. Philadelphia, Lippincott-Raven, 1998, p. 115-134